204 related articles for article (PubMed ID: 24956070)
21. Glycemic patterns detected by continuous subcutaneous glucose sensing in children and adolescents with type 1 diabetes mellitus treated by multiple daily injections vs continuous subcutaneous insulin infusion.
Weintrob N; Schechter A; Benzaquen H; Shalitin S; Lilos P; Galatzer A; Phillip M
Arch Pediatr Adolesc Med; 2004 Jul; 158(7):677-84. PubMed ID: 15237068
[TBL] [Abstract][Full Text] [Related]
22. Evaluation of a novel continuous glucose monitoring-based method for mealtime insulin dosing--the iBolus--in subjects with type 1 diabetes using continuous subcutaneous insulin infusion therapy: a randomized controlled trial.
Rossetti P; Ampudia-Blasco FJ; Laguna A; Revert A; Vehì J; Ascaso JF; Bondia J
Diabetes Technol Ther; 2012 Nov; 14(11):1043-52. PubMed ID: 23003329
[TBL] [Abstract][Full Text] [Related]
23. Relationships among different glycemic variability indices obtained by continuous glucose monitoring.
Saisho Y; Tanaka C; Tanaka K; Roberts R; Abe T; Tanaka M; Meguro S; Irie J; Kawai T; Itoh H
Prim Care Diabetes; 2015 Aug; 9(4):290-6. PubMed ID: 25456706
[TBL] [Abstract][Full Text] [Related]
24. Multicenter closed-loop insulin delivery study points to challenges for keeping blood glucose in a safe range by a control algorithm in adults and adolescents with type 1 diabetes from various sites.
Zisser H; Renard E; Kovatchev B; Cobelli C; Avogaro A; Nimri R; Magni L; Buckingham BA; Chase HP; Doyle FJ; Lum J; Calhoun P; Kollman C; Dassau E; Farret A; Place J; Breton M; Anderson SM; Dalla Man C; Del Favero S; Bruttomesso D; Filippi A; Scotton R; Phillip M; Atlas E; Muller I; Miller S; Toffanin C; Raimondo DM; De Nicolao G; Beck RW;
Diabetes Technol Ther; 2014 Oct; 16(10):613-22. PubMed ID: 25003311
[TBL] [Abstract][Full Text] [Related]
25. Continuous intraperitoneal insulin infusion versus subcutaneous insulin therapy in the treatment of type 1 diabetes: effects on glycemic variability.
van Dijk PR; Groenier KH; DeVries JH; Gans RO; Kleefstra N; Bilo HJ; Logtenberg SJ
Diabetes Technol Ther; 2015 Jun; 17(6):379-84. PubMed ID: 25856045
[TBL] [Abstract][Full Text] [Related]
26. Responses to continuous glucose monitoring in subjects with type 1 diabetes using continuous subcutaneous insulin infusion or multiple daily injections.
Rodbard D; Jovanovic L; Garg SK
Diabetes Technol Ther; 2009 Dec; 11(12):757-65. PubMed ID: 20001676
[TBL] [Abstract][Full Text] [Related]
27. Continuous Glucose Monitoring: A Review of Recent Studies Demonstrating Improved Glycemic Outcomes.
Rodbard D
Diabetes Technol Ther; 2017 Jun; 19(S3):S25-S37. PubMed ID: 28585879
[TBL] [Abstract][Full Text] [Related]
28. Comparison of CGM-Derived Measures of Glycemic Variability Between Pancreatogenic Diabetes and Type 2 Diabetes Mellitus.
Shivaprasad C; Aiswarya Y; Kejal S; Sridevi A; Anupam B; Ramdas B; Gautham K; Aarudhra P
J Diabetes Sci Technol; 2021 Jan; 15(1):134-140. PubMed ID: 31282179
[TBL] [Abstract][Full Text] [Related]
29. Clinical and Lifestyle Determinants of Continuous Glucose Monitoring Metrics in Insulin-Treated Patients with Type 2 Diabetes Mellitus.
Lee DY; Kim N; Jung I; Park SY; Yu JH; Seo JA; Kim J; Kim KJ; Kim NH; Yoo HJ; Kim SG; Choi KM; Baik SH; Park SM; Kim NH
Diabetes Metab J; 2023 Nov; 47(6):826-836. PubMed ID: 37614025
[TBL] [Abstract][Full Text] [Related]
30. Prolonged nocturnal hypoglycemia is common during 12 months of continuous glucose monitoring in children and adults with type 1 diabetes.
Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group
Diabetes Care; 2010 May; 33(5):1004-8. PubMed ID: 20200306
[TBL] [Abstract][Full Text] [Related]
31. Glycemic Outcomes in Adults With T1D Are Impacted More by Continuous Glucose Monitoring Than by Insulin Delivery Method: 3 Years of Follow-Up From the COMISAIR Study.
Šoupal J; Petruželková L; Grunberger G; Hásková A; Flekač M; Matoulek M; Mikeš O; Pelcl T; Škrha J; Horová E; Škrha J; Parkin CG; Svačina Š; Prázný M
Diabetes Care; 2020 Jan; 43(1):37-43. PubMed ID: 31530663
[TBL] [Abstract][Full Text] [Related]
32. Personal continuous glucose monitoring (CGM) in diabetes management: review of the literature and implementation for practical use.
Joubert M; Reznik Y
Diabetes Res Clin Pract; 2012 Jun; 96(3):294-305. PubMed ID: 22209014
[TBL] [Abstract][Full Text] [Related]
33. Real-time continuous glucose monitoring or continuous subcutaneous insulin infusion, what goes first?: results of a pilot study.
Moreno-Fernandez J; Gomez FJ; Gazquez M; Pedroche M; García-Manzanares A; Tenias JM; Benito P; Gomez IR
Diabetes Technol Ther; 2013 Jul; 15(7):596-600. PubMed ID: 23631604
[TBL] [Abstract][Full Text] [Related]
34. Simple Linear Support Vector Machine Classifier Can Distinguish Impaired Glucose Tolerance Versus Type 2 Diabetes Using a Reduced Set of CGM-Based Glycemic Variability Indices.
Longato E; Acciaroli G; Facchinetti A; Maran A; Sparacino G
J Diabetes Sci Technol; 2020 Mar; 14(2):297-302. PubMed ID: 30931604
[TBL] [Abstract][Full Text] [Related]
35. Effect of Education on Impaired Hypoglycemia Awareness and Glycemic Variability in Children and Adolescents with Type 1 Diabetes Mellitus.
Demir G; Özen S; Çetin H; Darcan Ş; Gökşen D
J Clin Res Pediatr Endocrinol; 2019 May; 11(2):189-195. PubMed ID: 30701953
[TBL] [Abstract][Full Text] [Related]
36. Sensor-augmented insulin pump therapy: results of the first randomized treat-to-target study.
Hirsch IB; Abelseth J; Bode BW; Fischer JS; Kaufman FR; Mastrototaro J; Parkin CG; Wolpert HA; Buckingham BA
Diabetes Technol Ther; 2008 Oct; 10(5):377-83. PubMed ID: 18715214
[TBL] [Abstract][Full Text] [Related]
37. Switching from Flash Glucose Monitoring to Continuous Glucose Monitoring on Hypoglycemia in Adults with Type 1 Diabetes at High Hypoglycemia Risk: The Extension Phase of the I HART CGM Study.
Reddy M; Jugnee N; Anantharaja S; Oliver N
Diabetes Technol Ther; 2018 Nov; 20(11):751-757. PubMed ID: 30265562
[TBL] [Abstract][Full Text] [Related]
38. Efficacy and safety of sensor augmented insulin pump therapy with low-glucose suspend feature in older adults: A retrospective study in Bogota, Colombia.
Morros-González E; Gómez AM; Henao Carrillo DC; Ursida V; Serrano S; Rondón Sepúlveda MA; Muñoz Velandia OM
Diabetes Metab Syndr; 2021; 15(3):649-653. PubMed ID: 33813236
[TBL] [Abstract][Full Text] [Related]
39. Study of MiniMed 640G Insulin Pump with SmartGuard in Prevention of Low Glucose Events in Adults with Type 1 Diabetes (SMILE): Design of a Hypoglycemia Prevention Trial with Continuous Glucose Monitoring Data as Outcomes.
De Valk HW; Lablanche S; Bosi E; Choudhary P; Silva JD; Castaneda J; Vorrink L; De Portu S; Cohen O
Diabetes Technol Ther; 2018 Nov; 20(11):758-766. PubMed ID: 30325656
[TBL] [Abstract][Full Text] [Related]
40. Accuracy of continuous glucose monitoring during exercise in type 1 diabetes pregnancy.
Kumareswaran K; Elleri D; Allen JM; Caldwell K; Nodale M; Wilinska ME; Amiel SA; Hovorka R; Murphy HR
Diabetes Technol Ther; 2013 Mar; 15(3):223-9. PubMed ID: 23445170
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
